Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections (Q28189095)
Jump to navigation
Jump to search
scientific article (publication date: December 2003)
- Revised Indications for the Use of Palivizumab and Respiratory Syncytial Virus Immune Globulin Intravenous for the Prevention of Respiratory Syncytial Virus Infections
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections |
scientific article (publication date: December 2003) |
|
Statements
Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections (English)
0 references
Revised Indications for the Use of Palivizumab and Respiratory Syncytial Virus Immune Globulin Intravenous for the Prevention of Respiratory Syncytial Virus Infections (English)
1 reference
December 2003
0 references
1 December 2003
1 reference
1 reference
112
1 reference
6 Pt 1
0 references
6
1 reference
1442-6
0 references
1442-1446
1 reference